SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Maulcoin

Maulcoin is capturing attention as a community-driven project that is rallying behind the development of its ticker and charting integration, with supporters emphasizing its focus on organic growth and transparent tokenomics. The community is actively using social platforms to boost visibility and volume, framing the project as a long-term alternative to the volatility of other meme coin sectors.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending as investors debate the impact of agentic AI competition against the company's strong fundamentals and established enterprise role. While the community remains polarized by recent volatility and technical support levels, many are focused on the upcoming product showcase as a potential catalyst to shift the narrative and challenge short interest.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Menlo Park, CA.

Snowflake Inc

Snowflake is facing intense volatility as the market reacts to a strong earnings report and AI growth metrics with a sharp sell-off, highlighting concerns over high valuations and competitive pressure from emerging AI models. Investors are currently torn between the company's solid revenue growth and the broader sector-wide repricing of high-multiple SaaS stocks amid fears of AI-driven disruption.

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

Organon & Co.

Organon is seeing significant market activity as investors react to a speculative but widely discussed 12-billion-dollar acquisition rumor involving Sun Pharma. While the company's substantial debt load and history of recurring takeover chatter are fueling skepticism among some, others are drawn to the stock's potential for a significant valuation reset if a deal materializes.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

Pepe is currently generating significant market conversation centered on speculative buzz regarding a potential ETF filing, which supporters argue highlights the meme coin's growing institutional legitimacy and cultural staying power. While some community members remain wary of volatility and broader sector instability, others are leveraging this institutional interest to fuel discussions about upcoming price rallies and long-term holding strategies.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is facing significant selling pressure amid a broader software sector rotation, fueled by a UBS downgrade and market-wide concerns that AI disruption may commoditize traditional IT enterprise platforms. While the community remains deeply divided between those viewing the decline as a rare value opportunity for a long-term enterprise staple and those warning of a structural breakdown in SaaS valuation models, heavy volume and RSI levels have many traders actively debating whether a capitulation bottom is finally forming.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending due to a major multi-year compute deal with Anthropic and an expanded capacity agreement with Meta, which have energized investor interest in the stock. While these partnerships highlight CoreWeave's role as a critical AI infrastructure provider, the community is actively debating the impact of a concurrent debt offering, weighing the massive growth potential against the implications of ongoing corporate dilution.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir Technologies is experiencing heightened volatility and intense social media chatter following an unprecedented endorsement by President Trump, which has sparked a heated debate between retail bulls betting on a short squeeze and institutional skeptics questioning the company's valuation compared to rivals like Anthropic. The stock is currently at the center of a liquidity battle as traders weigh the impact of potential new government defense contracts against critical bearish sentiment regarding the software sector's long-term outlook.

Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. The company was founded by Kevin D. Bunker and Cam Gallagher on December 23, 2014 and is headquartered in San Diego, CA.

Zentalis Pharmaceuticals Inc

Zentalis Pharmaceuticals is capturing significant investor attention as shares experience high volatility driven by speculation around upcoming pivotal trial data for its lead oncology candidate. The community is actively debating the company's valuation relative to its cash position, while split perspectives persist on whether the recent momentum represents a genuine breakout or a speculative short-term play.

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

Pudgy Penguins is trending as community members highlight its transition from a digital asset to a "phygital" powerhouse with significant retail presence in major stores and the launch of new utility products like a Visa-backed card. Investors are actively discussing the project's long-term growth potential and real-world revenue streams as they navigate volatility and accumulation opportunities.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Assertio Holdings, Inc. (NASDAQ: ASRT)

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Assertio Holdings, Inc. (NASDAQ: ASRT) $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Assertio...

Assertio Holdings, Inc. (NASDAQ:ASRT) Receives Average Rating of "Hold" from Brokerages

Shares of Assertio Holdings, Inc. (NASDAQ:ASRT - Get Free Report) have received an average rating of "Hold" from the five analysts that are currently covering the firm, Marketbeat Ratings reports...

Lake Street Capital Reiterates "Hold" Rating for Assertio (NASDAQ:ASRT)

Lake Street Capital reiterated a "hold" rating and set a $18.00 price target (down from $45.00) on shares of Assertio in a research note on Thursday...

Does Assertio (ASRT) Have the Potential to Rally 115.05% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 115.1% in Assertio (ASRT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Is AC Immune (ACIU) Stock Outpacing Its Medical Peers This Year?

Here is how AC Immune (ACIU) and Assertio (ASRT) have performed compared to their sector so far this year.

Assertio (NASDAQ:ASRT) Earns "Neutral" Rating from HC Wainwright

HC Wainwright reissued a "neutral" rating and issued a $18.00 target price (down from $35.00) on shares of Assertio in a report on Thursday...

<ul class="summary-bullets"><li>The cash consideration represents a 3% discount to the stock’s closing price on Tuesday.</li><li>The company didn’t elaborate on the value of the CVR but said that it is related to potential future milestones for its Sprix nasal spray.&nbsp;</li><li>The transaction, approved by the board of directors of both companies, is expected to close in the second quarter of 2026.</li></ul>Shares of Assertio Holdings, Inc. (ASRT) fell by over 1% after-hours on Wednesday after the company said that it has entered into an agreement to be acquired by Garda Therapeutics for a total cash consideration of $125.1 million.Under the deal, Garda will pay Assertio shareholders $18 per share in cash and a contingent value right (CVR). The cash consideration represents a 3% discount to the stock’s closing price on Tuesday.The company didn’t elaborate on the value of the CVR but said that it is related to potential future milestones for its Sprix nasal spray.The transaction, approved by the board of directors of both companies, is expected to close in the second quarter of 2026 and is subject to customary closing conditions, the pharmaceutical company said. Assertio’s common stock will no longer be listed for trading on Nasdaq following the closing of the deal, which follows the strategic review process initiated by the company in the first quarter of 2025.<h2 class="st-heading-2">Window Shop Period</h2>Assertio also said on Wednesday that its buyout agreement includes a 20-day “window-shop” period, meaning that the company is free to engage with other parties who may provide superior value in the period.A reduced breakup fee would apply if Assertio’s board terminates its agreement with Garda in favor of a superior bid during the period.<h2 class="st-heading-2">How Did Retail Traders React?</h2>On Stocktwits, retail sentiment around ASRT stock stayed within ‘bearish’ territory over the past 24 hours, while message volume remained at ‘low’ levels.Stocktwits users expressed disappointment over the deal.One user called the deal a ‘robbery.’<stembedurl>https://www.stocktwits.com/TikStockTok/message/649766893</stembedurl>Another user reiterated the prior user’s stance.<stembedurl>https://www.stocktwits.com/Chrissytina/message/649766497</stembedurl><a href="https://stocktwits.com/symbol/ASRT">ASRT stock</a> has gained nearly 130% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/tesla-chinese-rival-beat-it-with-first-us-long-haul-electric-truck-delivery/cZJf7VDRIAA">Tesla’s Chinese Rival Beat It With First US Long Haul Electric Truck Delivery — What Does This Mean For The EV Giant?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Global stock market chart and trading board - stock photo

ASRT Stock Drops After-Hours On Discounted Buyout Deal — Retail Calls It A ‘Robbery’ 

Under the deal, Garda Therapeutics will pay Assertio shareholders $18 per share in cash and a contingent value right.

Equity

Under the deal, Garda Therapeutics will pay Assertio shareholders $18 per share in cash and a contingent value right.


Assertio Announces Agreement to be Acquired by Garda Therapeutics

Assertio Holdings, Inc. (Assertio or the Company) (Nasdaq: ASRT), today announced a definitive agreement (the Garda Agreement) to be acquired by Garda Therapeutics (Garda or the Buyer) for $18 per...

TSP Capital Management Group LLC Has $227,000 Position in Assertio Holdings, Inc. $ASRT

TSP Capital Management Group LLC reduced its holdings in Assertio Holdings, Inc. (NASDAQ:ASRT - Free Report) by 92.1% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 25,056 shares of the company's stock after selling 291,819 shares during...

Assertio (ASRT) Surges 17.9%: Is This an Indication of Further Gains?

Assertio (ASRT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.

ASRT
Assertio Holdings Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ASRT News

ASRTAssertio Holdings Inc